Trade

Dishman Carbogen Amcis share price

High risk
  • 62%Low risk
  • 62%Moderate risk
  • 62%Balanced risk
  • 62%High risk
  • 62%Extreme risk
  • ₹170.60(2.37%)
    April 16, 2026 15:47:53 PM IST
    • NSE
    • BSE
  • Vol : 264.35 K (NSE + BSE)
    Last 20 day avg : 625.96 K

Dishman Carbogen Amcis is trading 2.37% upper at Rs 170.60 as compared to its last closing price. Dishman Carbogen Amcis has been trading in the price range of 170.90 & 165.00. Dishman Carbogen Amcis has given -32.64% in this year & 10.66% in the last 5 days. The company posted a net profit of -12.97 Crores in its last quarter.Listed peers of Dishman Carbogen Amcis include Dr Reddy's Laboratories (0.24%), Sun Pharmaceutical Industries (-0.21%), Cipla (0.33%).The Mutual Fund holding in Dishman Carbogen Amcis was at 1.08% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Dishman Carbogen Amcis was at 7.66% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 16, 2026, 08:26 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.47
    High volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.45
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    22.02
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -0.51
    Indicates undervaluation
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
165.00
Highest
170.90
52 week range
Lowest
129.00
Highest
321.15
Dishman Carbogen Amcis News
Dishman Carbogen Amcis Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bearish
1,221.250.241,01,944.2218.633.140.632.34
Sun Pharmaceutical Industries
Bearish
1,693.15-0.214,06,233.8336.245.770.920.50
Cipla
Moderately Bearish
1,230.750.3399,417.8522.953.870.870.81
Divi's Laboratories
Moderately Bullish
6,297.001.951,67,220.6478.6111.520.460.01
Torrent Pharmaceuticals
Bullish
4,158.350.061,41,172.6567.3217.10.8317.62
Mutual Fund Ownership
View all
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 5.32
  • % of AUM 0.23
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.03
  • % of AUM 0.13
Mirae Asset Nifty Total Market Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.01
  • % of AUM 0.01
Bandhan Nifty Total Market Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.01
  • % of AUM 0.01
Groww Nifty Total Market Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.03
  • % of AUM 0.01
Dishman Carbogen Amcis Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-03-18To consider Fund Raising
2026-02-03Quarterly Results
2025-12-27To consider Fund Raising
2025-11-04Quarterly Results
2025-08-12Quarterly Results & Fund raising
About the company Dishman Carbogen Amcis
  • IndustryBiotechnology & Drugs
  • ISININE385W01011
  • BSE Code540701
  • NSE CodeDCAL
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.
  • Management Info
  • Harshil DalalGlobal Chief Financial Officer
  • Shrima DaveCompliance Officer, Company Secretary
  • Arpit VyasGlobal Managing Director, Executive Director
  • Deohooti VyasWhole-Time Director
Dishman Carbogen Amcis Share Price FAQs

Dishman Carbogen Amcis is trading at 170.60 as on Thu Apr 16 2026 10:17:53. This is 2.37% upper as compared to its previous closing price of 166.65.

The market capitalization of Dishman Carbogen Amcis is 2698.40 Cr as on Thu Apr 16 2026 10:17:53.

The 52 wk high for Dishman Carbogen Amcis is 321.15 whereas the 52 wk low is 129.00

Dishman Carbogen Amcis can be analyzed on the following key metrics -

  • TTM P/E: 32.69
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: -

Dishman Carbogen Amcis reported a net profit of 3.24 Cr in 2025.

The Mutual Fund Shareholding was 1.08% at the end of 31 Dec 2025.

Quick Links
EQUITY QUICK LINKS
Dishman Carbogen Amcis QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Dishman Carbogen Amcis share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.